RAPT Therapeutics

$19.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.28 (-6.23%) Today

$0.00 (0.00%) As of 12:00 PM UTC after-hours

Why Robinhood?

You can buy or sell RAPT and other stocks, options, and ETFs commission-free!

About RAPT

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA. The listed name for RAPT is RAPT Therapeutics, Inc. Common Stock.

CEO

Brian Russell Wong

Employees

Headquarters

South San Francisco, California

Founded

2015

Market Cap

497.34M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

188.65K

High Today

$20.37

Low Today

$19.09

Open Price

$20.22

Volume

233.74K

52 Week High

$51.21

52 Week Low

$10.52

Collections

Analyst Ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

RAPT Earnings

-$12.41

-$8.27

-$4.14

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 30, Pre-Market